David Domzalski - Dec 31, 2021 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
President and CEO, Director
Signature
/s/ Mutya Harsch, attorney-in-fact for David Domzalski
Stock symbol
VYNE
Transactions as of
Dec 31, 2021
Transactions value $
-$7,025
Form type
4
Date filed
1/4/2022, 03:39 PM
Previous filing
Dec 2, 2021
Next filing
Mar 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability -$7.02K -6.89K -0.9% $1.02 761K Dec 31, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.